好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Novel Use of Dual Immunomodulation To Treat the Cerebellar Variant of Stiff-Person Syndrome (SPS)
Neuro-oncology
(-)
076
Authors/Disclosures
Soma Sengupta, MD, PhD, FAAN (Tufts Medical Center) Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Novocure. Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Bioventures. Dr. Sengupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. Dr. Sengupta has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bexion. Dr. Sengupta has stock in Amlal. The institution of Dr. Sengupta has received research support from ABTA. Dr. Sengupta has received intellectual property interests from a discovery or technology relating to health care.
Joung-Ho Rha, MD, PhD (Inha University Hospital Neurology) No disclosure on file
Daniel Tarsy, MD, FAAN No disclosure on file
Suriya A. Jeyapalan, MD, MPH (Tufts Medical Center) Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure.
Sarah A. O'Shea, MD (Boston University) Dr. O'Shea has nothing to disclose.